WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1891-01-01
- Employees
- 10K
- Market Cap
- -
Health Literacy Intervention for Informed Consent of Cancer Patients Considering Clinical Trial Participation
Not Applicable
Completed
- Conditions
- Cancer
- Interventions
- Behavioral: Decision Aid (DA)
- First Posted Date
- 2013-10-17
- Last Posted Date
- 2015-12-07
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 201
- Registration Number
- NCT01964222
- Locations
- 🇺🇸
Siteman Cancer Center, St. Louis, Missouri, United States
3D Breast Imaging for Cosmetic and Reconstructive Breast Surgery
Not Applicable
Completed
- Conditions
- HypomastiaPrimary Breast Augmentation
- Interventions
- Device: 3D Imaging
- First Posted Date
- 2013-10-17
- Last Posted Date
- 2017-12-26
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 100
- Registration Number
- NCT01964105
- Locations
- 🇺🇸
West County Plastic Surgeons of Washington University, Saint Louis, Missouri, United States
Bilateral vs Unilateral CTR
- Conditions
- Carpal Tunnel Syndrome
- First Posted Date
- 2013-10-11
- Last Posted Date
- 2013-10-11
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 120
- Registration Number
- NCT01961011
- Locations
- 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States
Paclitaxel and BKM120 Before Surgery in Treating Patients With Stage II or III Estrogen Receptor-Positive and HER2-Negative Breast Cancer
- First Posted Date
- 2013-10-01
- Last Posted Date
- 2014-12-08
- Lead Sponsor
- Washington University School of Medicine
- Registration Number
- NCT01953445
Effects of Xenin-25 on Insulin Secretion and Gastric Emptying in Humans With and Without a Complete Truncal Vagotomy
Phase 1
Withdrawn
- Conditions
- Does the Vagus Nerve Mediate the Effects of Xenin-25
- Interventions
- Drug: Graded Glucose Infusion with PlaceboDrug: Graded Glucose Infusion with GIP AloneDrug: Graded Glucose Infusion with xenin-25 aloneDrug: Graded Glucose Infusion with GIP plus xenin-25Drug: Meal Tolerance Test with PlaceboDrug: Meal Tolerance Test with xenin-25
- First Posted Date
- 2013-09-27
- Last Posted Date
- 2018-04-26
- Lead Sponsor
- Washington University School of Medicine
- Registration Number
- NCT01951716
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
The Role of Cholinergic Signaling for Mediating the Effects of GIP and/or Xenin-25 on Insulin Secretion
Phase 1
Completed
- Conditions
- Pre-diabetes
- Interventions
- Drug: ControlDrug: GIP plus Xenin-25 without atropineDrug: GIP plus Xenin-25 with atropine
- First Posted Date
- 2013-09-27
- Last Posted Date
- 2018-05-25
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 15
- Registration Number
- NCT01951729
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
LAAM-HAART PET Imaging
Early Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2013-09-05
- Last Posted Date
- 2017-12-13
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 10
- Registration Number
- NCT01935830
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Effect of Reducing Uric Acid on Insulin Sensitivity and Oxidative Status
Not Applicable
Completed
- Conditions
- ObesityMetabolic SyndromeHyperuricemia
- Interventions
- First Posted Date
- 2013-08-29
- Last Posted Date
- 2018-08-14
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 31
- Registration Number
- NCT01931527
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Efficacy Study of Sitagliptin to Prevent New-onset Diabetes After Kidney Transplant
Phase 4
Completed
- Conditions
- Posttransplant Diabetes Mellitus
- Interventions
- Drug: Placebo
- First Posted Date
- 2013-08-23
- Last Posted Date
- 2022-12-30
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 61
- Registration Number
- NCT01928199
- Locations
- 🇺🇸
Washington University, Saint Louis, Missouri, United States
Combination Chemotherapy in Treating Patients With Advanced Stomach, Gastroesophageal, or Esophageal Cancer
Phase 2
Completed
- Conditions
- Stomach NeoplasmsEsophageal Neoplasms
- Interventions
- First Posted Date
- 2013-08-23
- Last Posted Date
- 2020-08-25
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 67
- Registration Number
- NCT01928290
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
© Copyright 2025. All Rights Reserved by MedPath